All Stories

  1. Effect of tezepelumab on exacerbation-related oral corticosteroid use in NAVIGATOR
  2. Impact of COVID-19 on treatments’ dispensations for chronic airways diseases in France
  3. Late Breaking Abstract - Severe Asthma Prevalence, Care Pathways, and Health Care Resource Utilization in France
  4. The six million dollar man
  5. Targeted literature review: burden of disease associated with severe and uncontrolled asthma in France, Germany, Italy, Spain and the UK
  6. LAM is another small airway disease: lessons from microCT
  7. How can we minimise the use of regular oral corticosteroids in asthma?
  8. Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship
  9. Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma
  10. Systematic review and MAIC of OCS reduction with biologic asthma treatments
  11. Qualas: Quality of Life and burden in asthma, a comparison between uncontrolled severe asthma and controlled moderate/severe asthma
  12. CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis
  13. Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency
  14. Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review
  15. Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design
  16. Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials
  17. Future treatment for asthma
  18. Club cells and CC16: another “smoking gun”? (With potential bullets against COPD)